Transforming growth factor-β (TGF-β) signaling is a well-known oncogenic pathway driving CRC; it acts as an oncogenic factor by creating an immune-suppressive tumor microenvironment, and inducing tumor cell proliferation, angiogenesis, and metastatic spread (29). This evidence concerns the gene TGFB1 and colorectal carcinoma.